Luther King Capital Management (LKCM)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $435K | Buy |
829
+1
| +0.1% | +$525 | ﹤0.01% | 484 |
|
|
2025
Q1 | $525K | Hold |
828
| – | – | ﹤0.01% | 459 |
|
|
2024
Q4 | $590K | Sell |
828
-14
| -2% | -$9.97K | ﹤0.01% | 442 |
|
|
2024
Q3 | $885K | Buy |
842
+11
| +1% | +$11.6K | ﹤0.01% | 415 |
|
|
2024
Q2 | $873K | Buy |
831
+3
| +0.4% | +$3.15K | ﹤0.01% | 414 |
|
|
2024
Q1 | $797K | Hold |
828
| – | – | ﹤0.01% | 422 |
|
|
2023
Q4 | $727K | Hold |
828
| – | – | ﹤0.01% | 425 |
|
|
2023
Q3 | $681K | Hold |
828
| – | – | ﹤0.01% | 419 |
|
|
2023
Q2 | $595K | Sell |
828
-28
| -3% | -$20.1K | ﹤0.01% | 456 |
|
|
2023
Q1 | $703K | Sell |
856
-274
| -24% | -$225K | ﹤0.01% | 425 |
|
|
2022
Q4 | $815K | Sell |
1,130
-73
| -6% | -$52.7K | ﹤0.01% | 401 |
|
|
2022
Q3 | $829K | Sell |
1,203
-611
| -34% | -$421K | ﹤0.01% | 394 |
|
|
2022
Q2 | $1.07M | Buy |
1,814
+160
| +10% | +$94.6K | 0.01% | 381 |
|
|
2022
Q1 | $1.16M | Hold |
1,654
| – | – | 0.01% | 377 |
|
|
2021
Q4 | $1.05M | Sell |
1,654
-210
| -11% | -$133K | ﹤0.01% | 408 |
|
|
2021
Q3 | $1.13M | Hold |
1,864
| – | – | 0.01% | 394 |
|
|
2021
Q2 | $1.04M | Buy |
1,864
+1,436
| +336% | +$802K | 0.01% | 412 |
|
|
2021
Q1 | $203K | Hold |
428
| – | – | ﹤0.01% | 538 |
|
|
2020
Q4 | $207K | Sell |
428
-102
| -19% | -$49.3K | ﹤0.01% | 536 |
|
|
2020
Q3 | $297K | Buy |
530
+32
| +6% | +$17.9K | ﹤0.01% | 468 |
|
|
2020
Q2 | $311K | Buy |
+498
| New | +$311K | ﹤0.01% | 451 |
|
|
2018
Q1 | – | Sell |
-825
| Closed | -$310K | – | 534 |
|
|
2017
Q4 | $310K | Hold |
825
| – | – | ﹤0.01% | 460 |
|
|
2017
Q3 | $369K | Buy |
825
+145
| +21% | +$64.9K | ﹤0.01% | 431 |
|
|
2017
Q2 | $334K | Sell |
680
-50
| -7% | -$24.6K | ﹤0.01% | 428 |
|
|
2017
Q1 | $283K | Sell |
730
-295
| -29% | -$114K | ﹤0.01% | 452 |
|
|
2016
Q4 | $376K | Sell |
1,025
-375
| -27% | -$138K | ﹤0.01% | 427 |
|
|
2016
Q3 | $563K | Sell |
1,400
-70
| -5% | -$28.2K | 0.01% | 388 |
|
|
2016
Q2 | $513K | Buy |
1,470
+140
| +11% | +$48.9K | 0.01% | 397 |
|
|
2016
Q1 | $479K | Buy |
1,330
+350
| +36% | +$126K | ﹤0.01% | 402 |
|
|
2015
Q4 | $532K | Sell |
980
-220
| -18% | -$119K | 0.01% | 408 |
|
|
2015
Q3 | $558K | Sell |
1,200
-160
| -12% | -$74.4K | 0.01% | 404 |
|
|
2015
Q2 | $694K | Buy |
1,360
+25
| +2% | +$12.8K | 0.01% | 403 |
|
|
2015
Q1 | $603K | Sell |
1,335
-110
| -8% | -$49.7K | 0.01% | 411 |
|
|
2014
Q4 | $593K | Hold |
1,445
| – | – | ﹤0.01% | 419 |
|
|
2014
Q3 | $521K | Buy |
1,445
+275
| +24% | +$99.2K | ﹤0.01% | 450 |
|
|
2014
Q2 | $330K | Buy |
1,170
+270
| +30% | +$76.2K | ﹤0.01% | 487 |
|
|
2014
Q1 | $270K | Buy |
+900
| New | +$270K | ﹤0.01% | 485 |
|